The Uncertain Path Forward for Psychedelic Medicine
After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its...
After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its...
The agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in...